{
    "name": "Schedule II",
    "number": "16",
    "text": "\u00a7329-16\u00a0 Schedule II.\u00a0 (a)\u00a0 The controlled substances listed in this section are included in schedule II.\n\u00a0\u00a0\u00a0\u00a0 (b)\u00a0 Any of the following substances, except those narcotic drugs listed in other schedules, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, including the following:\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (A)\u00a0 Raw opium;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (B)\u00a0 Opium extracts;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (C)\u00a0 Opium fluid;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (D)\u00a0 Powdered opium;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (E)\u00a0 Granulated opium;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (F)\u00a0 Codeine;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (G)\u00a0 Ethylmorphine;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (H)\u00a0 Etorphine hydrochloride;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (I)\u00a0 Hydrocodone;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (J)\u00a0 Hydromorphone;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (K)\u00a0 Metopon;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (L)\u00a0 Morphine;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (M)\u00a0 Oxycodone;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (N)\u00a0 Oxymorphone;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (O)\u00a0 Thebaine;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (P)\u00a0 Dihydroetorphine;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (Q)\u00a0 Oripavine; and\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (R)\u00a0 Tincture of opium;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Any salt, compound, isomer, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (1), but not including the isoquinoline alkaloids of opium;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Opium poppy and poppy straw;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocanized coca leaves or extractions which do not contain cocaine or ecgonine; cocaine or any salt or isomer thereof; and\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid, or powder form that contains the phenanthrene alkaloids of the opium poppy).\n\u00a0\u00a0\u00a0\u00a0 (c)\u00a0 Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Alfentanil;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Alphaprodine;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Anileridine;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Bezitramide;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Bulk Dextropropoxyphene (nondosage form);\n\u00a0\u00a0\u00a0\u00a0 (6)  Carfentanil;\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 Dihydrocodeine;\n\u00a0\u00a0\u00a0\u00a0 (8)\u00a0 Diphenoxylate;\n\u00a0\u00a0\u00a0\u00a0 (9)\u00a0 Fentanyl;\n\u00a0\u00a0\u00a0 (10)\u00a0 Isomethadone;\n\u00a0\u00a0\u00a0 (11)\u00a0 Levo-alphacetylmethadol (LAAM);\n\u00a0\u00a0\u00a0 (12)\u00a0 Levomethorphan;\n\u00a0\u00a0\u00a0 (13)\u00a0 Levorphanol;\n\u00a0\u00a0\u00a0 (14)\u00a0 Metazocine;\n\u00a0\u00a0\u00a0 (15)\u00a0 Methadone;\n\u00a0\u00a0\u00a0 (16)\u00a0 Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;\n\u00a0\u00a0\u00a0 (17)\u00a0 Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenyl-propane-carboxylic acid;\n\u00a0\u00a0\u00a0 (18)\u00a0 Pethidine (Meperidine);\n\u00a0\u00a0\u00a0 (19)\u00a0 Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;\n\u00a0\u00a0\u00a0 (20)\u00a0 Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;\n\u00a0\u00a0\u00a0 (21)\u00a0 Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;\n\u00a0\u00a0\u00a0 (22)\u00a0 Phenazocine;\n\u00a0\u00a0\u00a0 (23)\u00a0 Piminodine;\n\u00a0\u00a0\u00a0 (24)\u00a0 Racemethorphan;\n\u00a0\u00a0\u00a0 (25)\u00a0 Racemorphan;\n\u00a0\u00a0\u00a0 (26)\u00a0 Remifentanil;\n\u00a0\u00a0\u00a0 (27)\u00a0 Sufentanil; and\n\u00a0\u00a0\u00a0 (28)\u00a0 Tapentadol.\n\u00a0\u00a0\u00a0\u00a0 (d)\u00a0 Depressants.\u00a0 Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Amobarbital;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Glutethimide;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Pentobarbital;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Phencyclidine;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Secobarbital.\n\u00a0\u00a0\u00a0\u00a0 (e)\u00a0 Stimulants.\u00a0 Any material, compound, mixture, or preparation which contains any quantity of the following substances having a danger or probable danger associated with a stimulant effect on the central nervous system:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Amphetamine, its salts, optical isomers, and salts of its optical isomers;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Any substance which contains any quantity of methamphetamine, including its salts, isomers, and salts of isomers;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Phenmetrazine and its salts;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Methylphenidate; and\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Lisdexamfetamine, its salts, isomers, and salts of its isomers.\n\u00a0\u00a0\u00a0\u00a0 (f)\u00a0 Immediate precursor. \u00a0Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Immediate precursor to amphetamine and methamphetamine:\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (A)\u00a0 Phenylacetone, phenyl-2-propanone(P2P), benzyl methyl ketone, methyl benzyl ketone;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Immediate precursors to phencyclidine (PCP):\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (A)\u00a0 1-phenylcyclohexylamine; and\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (B)\u00a0 1-piperidinocyclohexanecarbonitrile(PCC); or\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Immediate precursor to Fentanyl:\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (A)\u00a0 4\u2011anilino-N-phenethyl-4-piperidine (ANPP).\n\u00a0\u00a0\u00a0\u00a0 (g)\u00a0 Hallucinogenic substances, unless listed in another schedule, shall include:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Nabilone. [L 1972, c 10, pt of \u00a71 and am c 114, \u00a72(2); am L 1974, c 217, \u00a72; am L 1975, c 26, \u00a71; am L 1978, c 68, \u00a73; am L 1979, c 194, \u00a72; am L 1981, c 125, \u00a7\u00a71, 2; am L 1984, c 166, \u00a72; am L 1985, c 150, \u00a72; am L 1987, c 203, \u00a71; am L 1988, c 59, \u00a72; am L 1990, c 138, \u00a74; am L 1991, c 159, \u00a77; am L 1995, c 122, \u00a72; am L 1997, c 356, \u00a72; am L 2000, c 98, \u00a7\u00a72, 3; am L 2001, c 203, \u00a73; am L 2002, c 165, \u00a71; am L 2003, c 151, \u00a73; am L 2008, c 119, \u00a74; am L 2009, c 117, \u00a7\u00a71, 2; am L 2010, c 123, \u00a72; am L 2011, c 73, \u00a72; am L 2012, c 29, \u00a72; am L 2013, c 48, \u00a72]\n\u00a0\nCase Notes\n\u00a0\n\u00a0 Method used to prove that capsules of methaqualone hydrochloride contained methaqualone accepted as evidence.\u00a0 1 H. App. 31, 613 P.2d 919."
}